Torrent Pharmaceuticals has increased its stake in J.B. Chemicals & Pharmaceuticals by acquiring 3,782,566 equity shares. This acquisition, executed on January 23, 2026, was facilitated through a share purchase agreement with certain employees of J.B. Chemicals. Following the transaction, Torrent Pharmaceuticals’ total shareholding in J.B. Chemicals has increased to 48.78% of the total voting capital.
Share Acquisition Details
Torrent Pharmaceuticals has acquired 3,782,566 equity shares of J.B. Chemicals & Pharmaceuticals. The transaction occurred on January 23, 2026, and was executed under a share purchase agreement (SPA) finalized on July 3, 2025.
Impact on Shareholding
Prior to this acquisition, Torrent Pharmaceuticals held 74,482,836 shares, representing 46.43% of the total voting capital in J.B. Chemicals. Following the acquisition of the additional shares, Torrent Pharmaceuticals now holds a total of 78,265,402 shares, which constitutes 48.78% of the total voting capital.
Terms of the Acquisition
The acquisition was executed via off-market transfer, in accordance with the share purchase agreement made with select employees of J.B. Chemicals. This transaction alters Torrent Pharmaceuticals’ position in J.B. Chemicals.
Source: BSE
